Qi Bian

879 total citations
25 papers, 681 citations indexed

About

Qi Bian is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, Qi Bian has authored 25 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Nephrology. Recurrent topics in Qi Bian's work include Renal Diseases and Glomerulopathies (7 papers), Inflammasome and immune disorders (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Qi Bian is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Inflammasome and immune disorders (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Qi Bian collaborates with scholars based in China, United States and Sweden. Qi Bian's co-authors include Xiaobin Mei, Jiajun Fan, Dianwen Ju, Tao Ding, Jingyun Luan, Shaofei Wang, Xuyao Zhang, Yilan Shen, Wei Chen and Jan Novák and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Qi Bian

23 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Bian China 13 322 223 122 85 76 25 681
Laura Márquez‐Expósito Spain 15 400 1.2× 269 1.2× 171 1.4× 77 0.9× 91 1.2× 31 916
Nagaraj Manickam India 12 246 0.8× 110 0.5× 135 1.1× 58 0.7× 61 0.8× 16 676
Huabin Ma China 13 502 1.6× 187 0.8× 140 1.1× 121 1.4× 97 1.3× 26 849
Michael S. Balzer Germany 17 414 1.3× 320 1.4× 151 1.2× 73 0.9× 49 0.6× 26 927
Dalia El‐Gamal United States 12 237 0.7× 119 0.5× 170 1.4× 82 1.0× 78 1.0× 30 763
Danyi Yang China 14 260 0.8× 329 1.5× 95 0.8× 111 1.3× 163 2.1× 28 720
Hermann Joseph Gröne Germany 8 323 1.0× 257 1.2× 58 0.5× 145 1.7× 78 1.0× 8 863
Zongyu Zheng United States 17 404 1.3× 222 1.0× 163 1.3× 77 0.9× 46 0.6× 27 830
Mohsen Honarpisheh Germany 15 395 1.2× 191 0.9× 235 1.9× 101 1.2× 50 0.7× 24 801
Massimo Papale Italy 15 348 1.1× 161 0.7× 41 0.3× 143 1.7× 47 0.6× 30 676

Countries citing papers authored by Qi Bian

Since Specialization
Citations

This map shows the geographic impact of Qi Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Bian more than expected).

Fields of papers citing papers by Qi Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Bian. The network helps show where Qi Bian may publish in the future.

Co-authorship network of co-authors of Qi Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Bian. A scholar is included among the top collaborators of Qi Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Bian. Qi Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shuangxi, Dexia Kong, Jing Xu, et al.. (2025). Efficacy of Telitacicept in treating IgA vasculitis nephritis: a two-case report. Frontiers in Immunology. 16. 1564242–1564242.
3.
Bian, Qi, et al.. (2023). ANA‐negative severe lupus‐like presentation: Is it lupus or not?. SHILAP Revista de lepidopterología. 11(11). e8145–e8145. 1 indexed citations
4.
Cao, Zhonglian, Hui Zhao, Jiajun Fan, et al.. (2023). Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. Cell Death Discovery. 9(1). 8–8. 16 indexed citations
5.
Shen, Yilan, Yuqing Xu, Pei Kang Shen, et al.. (2023). A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation. Applied Microbiology and Biotechnology. 107(7-8). 2561–2576. 4 indexed citations
6.
Bian, Qi, et al.. (2022). Mass spectrometry-based N-glycosylation analysis in kidney disease. Frontiers in Molecular Biosciences. 9. 976298–976298. 9 indexed citations
7.
Wang, Haiyan, et al.. (2022). In-depth profiling of urinary N-glycome in diabetic kidney disease by ultrafast glycoprotein immobilization for glycan extraction (UltraGIG). Analytica Chimica Acta. 1221. 340144–340144. 3 indexed citations
8.
Xiao, Ming, Qi Bian, Yimin Lao, et al.. (2021). SENP3 loss promotes M2 macrophage polarization and breast cancer progression. Molecular Oncology. 16(4). 1026–1044. 62 indexed citations
9.
Bian, Qi, Joshua C. Anderson, Xianwen Zhang, et al.. (2021). Mesangioproliferative Kidney Diseases and Platelet-Derived Growth Factor–Mediated AXL Phosphorylation. Kidney Medicine. 3(6). 1003–1013.e1. 4 indexed citations
10.
Shen, Yilan, Xin Jin, Wei Chen, et al.. (2020). Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses. Applied Microbiology and Biotechnology. 104(13). 5889–5898. 27 indexed citations
11.
Shen, Yilan, Wei Chen, Lei Han, et al.. (2020). VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharmaceutica Sinica B. 11(1). 127–142. 44 indexed citations
12.
Ding, Tao, Shaofei Wang, Xuyao Zhang, et al.. (2018). Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine. 41. 45–53. 160 indexed citations
14.
Novák, Jan, Dana V. Rizk, Kazuo Takahashi, et al.. (2015). New Insights into the Pathogenesis of IgA Nephropathy. Kidney Diseases. 1(1). 8–18. 61 indexed citations
15.
Song, Bin, Qi Bian, Gang Li, et al.. (2015). Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy. PLoS ONE. 10(3). e0120694–e0120694. 21 indexed citations
16.
Song, Bin, Qi Bian, Yijie Zhang, et al.. (2015). Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation. Molecular Cancer. 14(1). 177–177. 43 indexed citations
17.
Song, Bin, Qi Bian, Chenghao Shao, et al.. (2015). Sox2 function as a negative regulator to control HAMP expression. Biological Research. 48(1). 23–23.
18.
Meng, Yan, Qun Xie, Wenjing Yi, et al.. (2015). miR-98 protects endothelial cells against hypoxia/reoxygenation induced-apoptosis by targeting caspase-3. Biochemical and Biophysical Research Communications. 467(3). 595–601. 32 indexed citations
19.
Wang, Jiafeng, et al.. (2014). miRNA expression profile in rat kidney during renal ischemia/reperfusion injury:screening and analysis. Academic Journal of Second Military Medical University. 35(5). 465–465. 1 indexed citations
20.
Li, Bai‐Rong, Guowu Zhou, Qi Bian, & Bin Song. (2012). Lack of Association between the hOGG1 Ser326Cys Polymorphism and Gastric Cancer Risk: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 13(4). 1145–1149. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026